These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22336559)

  • 1. [The relationship of antidiabetic drugs and cancer risk].
    Gu YJ; Jia WP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Nov; 32(11):1170-3. PubMed ID: 22336559
    [No Abstract]   [Full Text] [Related]  

  • 2. Type 2 diabetes mellitus and risk of malignancy: is there a strategy to identify a subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism?
    Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
    Diabet Med; 2011 Mar; 28(3):276-86. PubMed ID: 21309835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where now for insulin glargine--a time for pragmatic medicine?
    Thomson GA; Craig R
    Int J Clin Pract; 2009 Oct; 63(10):1413-5. PubMed ID: 19689485
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes mellitus and the risk of cancer.
    Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
    Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes medications and cancer: a way out of uncertainty.
    Gallo M; Esposito K; Giugliano D
    Diabetes Res Clin Pract; 2012 Aug; 97(2):175-7. PubMed ID: 22560795
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
    Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
    Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin glargine (Lantus) and cancer risk.
    Med Lett Drugs Ther; 2009 Aug; 51(1319):67-8. PubMed ID: 19696708
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs.
    McFarland MS; Cripps R
    Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putting insulin glargine and malignancies into perspective.
    Ehninger G; Schmidt AH
    Oncologist; 2009 Dec; 14(12):1169-74. PubMed ID: 20007644
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs.
    Panicker GK; Karnad DR; Salvi V; Kothari S
    J Assoc Physicians India; 2012 Jan; 60():56-61. PubMed ID: 22715547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes, insulin therapy, and colorectal cancer.
    Renehan AG; Shalet SM
    BMJ; 2005 Mar; 330(7491):551-2. PubMed ID: 15760973
    [No Abstract]   [Full Text] [Related]  

  • 12. Pioglitazone safe, so save.
    Banerjee S
    J Assoc Physicians India; 2012 Jan; 60():62-6. PubMed ID: 22715548
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral antidiabetic drugs--1. For each patient the proper drug].
    Bachmann W
    MMW Fortschr Med; 2000 Mar; 142(9):41-4. PubMed ID: 10795481
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes and cancer: Could vitamin D provide the link?
    Ahmad S; Chowdhury TA; Boucher BJ
    J Diabetes Complications; 2013; 27(2):184-90. PubMed ID: 23164631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.
    Parks M; Rosebraugh C
    N Engl J Med; 2010 Mar; 362(9):774-7. PubMed ID: 20164475
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes therapy and cancer risk: where do we stand when treating patients?
    Ching Sun GE; Kashyap SR; Nasr C
    Cleve Clin J Med; 2014 Oct; 81(10):620-8. PubMed ID: 25274656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis confirms raised risk of bladder cancer from pioglitazone.
    Kermode-Scott B
    BMJ; 2012 Jul; 345():e4541. PubMed ID: 22763399
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection.
    Kawaguchi T; Taniguchi E; Morita Y; Shirachi M; Tateishi I; Nagata E; Sata M
    Liver Int; 2010 Mar; 30(3):479-86. PubMed ID: 20040053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Type 2 diabetes: explosive issues in routine care].
    Aumiller J
    MMW Fortschr Med; 2009 Oct; 151(42):20. PubMed ID: 19938775
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antidiabetic drugs and drug interactions].
    Griese-Mammen N; Gerdemann A
    MMW Fortschr Med; 2012 Oct; 154(17):65-8. PubMed ID: 23088041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.